Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: reassessing efficacy using endpoints from clinical trials

ABSTRACT: A live attenuated HSV virus vaccine, VC2 was compared to a subunit HSV vaccine, glycoprotein D (gD2) administered with the adjuvant, MPL/Alum using the guinea pig model of genital herpes

SUBMITTER: FERNANDO BRAVO 

PROVIDER: S-BSST242 | biostudies-other |

SECONDARY ACCESSION(S):

REPOSITORIES: biostudies-other